MINT-COPD trial completes recruitment with 80th participant
Leicester researchers said the final participant in the MINT-COPD trial of RJx-01 for people hospitalised with severe COPD flare-ups was seen this week.
“hospital admissions can result in significant loss of muscle strength and physical function”— Research at Leicester's Hospitals
Research at Leicester's Hospitals announced on X that recruitment to the MINT-COPD trial is complete, after the 80th and final participant was seen this week.
The post described the milestone as important for the study, which is being delivered through the NIHR Leicester BRC at Leicester's Hospitals. The trial seeks to improve recovery and quality of life for people living with COPD after a hospital admission.
MINT-COPD stands for Maintaining the Integrity of Muscle Trial in Chronic Obstructive Pulmonary Disease. According to the post, it is investigating whether a novel treatment, known as RJx-01, can help preserve muscle health and improve recovery for people hospitalised with severe flare-ups of chronic obstructive pulmonary disease.
The post said COPD is a major cause of ill health worldwide and that hospital admissions can result in significant loss of muscle strength and physical function, affecting patients' independence and quality of life.
The post did not report any trial results. It linked to a fuller story and tagged the University of Leicester, Rejuven8Biomed and Wellcome Leap.
Original source
“hospital admissions can result in significant loss of muscle strength and physical function”
— Research at Leicester's Hospitals View the post on X